These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33058042)

  • 1. Imlifidase: First Approval.
    Al-Salama ZT
    Drugs; 2020 Nov; 80(17):1859-1864. PubMed ID: 33058042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imlifidase therapy: exploring its clinical uses.
    Rostaing L; Noble J; Malvezzi P; Jouve T
    Expert Opin Pharmacother; 2023 Feb; 24(2):259-265. PubMed ID: 36404277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients.
    Lorant T; Bengtsson M; Eich T; Eriksson BM; Winstedt L; Järnum S; Stenberg Y; Robertson AK; Mosén K; Björck L; Bäckman L; Larsson E; Wood K; Tufveson G; Kjellman C
    Am J Transplant; 2018 Nov; 18(11):2752-2762. PubMed ID: 29561066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imlifidase Desensitization in Crossmatch-positive, Highly Sensitized Kidney Transplant Recipients: Results of an International Phase 2 Trial (Highdes).
    Jordan SC; Legendre C; Desai NM; Lorant T; Bengtsson M; Lonze BE; Vo AA; Runström A; Laxmyr L; Sjöholm K; Schiött Å; Sonesson E; Wood K; Winstedt L; Kjellman C; Montgomery RA
    Transplantation; 2021 Aug; 105(8):1808-1817. PubMed ID: 33093408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imlifidase Desensitization in HLA-incompatible Kidney Transplantation: Finding the Sweet Spot.
    de Weerd AE; Roelen DL; van de Wetering J; Betjes MGH; Heidt S; Reinders MEJ
    Transplantation; 2024 Feb; 108(2):335-345. PubMed ID: 37340532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imlifidase for the treatment of anti-HLA antibody-mediated processes in kidney transplantation.
    Huang E; Maldonado AQ; Kjellman C; Jordan SC
    Am J Transplant; 2022 Mar; 22(3):691-697. PubMed ID: 34467625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New approach to desensitization in solid organ transplantation-imlifidase.
    Durlik M
    Front Transplant; 2022; 1():951360. PubMed ID: 38994389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First use of imlifidase desensitization in a highly sensitized lung transplant candidate: a case report.
    Roux A; Bunel V; Belousova N; Messika J; Tanaka S; Salpin M; Roussel A; Beaumont-Azuar L; Picard C; Brugiere O; Devaquet J; Sage E; Le Guen M; Taupin JL; Devriese M; Glorion M; Parquin F
    Am J Transplant; 2023 Feb; 23(2):294-297. PubMed ID: 36695676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IdeS (Imlifidase): A Novel Agent That Cleaves Human IgG and Permits Successful Kidney Transplantation Across High-strength Donor-specific Antibody.
    Lonze BE; Tatapudi VS; Weldon EP; Min ES; Ali NM; Deterville CL; Gelb BE; Benstein JA; Dagher NN; Wu M; Montgomery RA
    Ann Surg; 2018 Sep; 268(3):488-496. PubMed ID: 30004918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes at 3 years posttransplant in imlifidase-desensitized kidney transplant patients.
    Kjellman C; Maldonado AQ; Sjöholm K; Lonze BE; Montgomery RA; Runström A; Lorant T; Desai NM; Legendre C; Lundgren T; von Zur Mühlen B; Vo AA; Olsson H; Jordan SC
    Am J Transplant; 2021 Dec; 21(12):3907-3918. PubMed ID: 34236770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney transplant in highly sensitized patients after desensitization with plasmapheresis and low-dose intravenous immunoglobulin.
    Yuan XP; Wang CX; Gao W; Fu Q; He XS
    Exp Clin Transplant; 2010 Jun; 8(2):130-5. PubMed ID: 20565369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imlifidase-generated Single-cleaved IgG: Implications for Transplantation.
    Bockermann R; Järnum S; Runström A; Lorant T; Winstedt L; Palmqvist N; Kjellman C
    Transplantation; 2022 Jul; 106(7):1485-1496. PubMed ID: 34966107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation.
    Jordan SC; Lorant T; Choi J; Kjellman C; Winstedt L; Bengtsson M; Zhang X; Eich T; Toyoda M; Eriksson BM; Ge S; Peng A; Järnum S; Wood KJ; Lundgren T; Wennberg L; Bäckman L; Larsson E; Villicana R; Kahwaji J; Louie S; Kang A; Haas M; Nast C; Vo A; Tufveson G
    N Engl J Med; 2017 Aug; 377(5):442-453. PubMed ID: 28767349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imlifidase in kidney transplantation.
    Kanbay M; Copur S; Guldan M; Topcu AU; Ozbek L; Hasbal B; Süsal C; Kocak B; Callemeyn J; Segelmark M
    Clin Kidney J; 2024 Mar; 17(3):sfae033. PubMed ID: 38504664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of Desensitization Therapy in Immunologically High-Risk Kidney Transplantation: Single-Center Experience.
    Sinangil A; Ucar ZA; Koc Y; Barlas S; Abouzahir S; Ecder ST; Akin EB
    Transplant Proc; 2019 Sep; 51(7):2268-2273. PubMed ID: 31358450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chop-Chop: The Future of Bacterial Enzymes in Transfusion Medicine.
    Klontz EH
    Transfus Med Rev; 2022 Oct; 36(4):246-251. PubMed ID: 36150947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of imlifidase in solid organ transplantation.
    Lonze BE
    Expert Opin Biol Ther; 2021 Feb; 21(2):135-143. PubMed ID: 33180664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desensitization in the Setting of HLA-Incompatible Kidney Transplant.
    Malvezzi P; Jouve T; Noble J; Rostaing L
    Exp Clin Transplant; 2018 Aug; 16(4):367-375. PubMed ID: 29863455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of imlifidase treatment on immunoglobulins in an HLA-hypersensitized lupus nephritis patient with anti-SSA/SSB antibodies after kidney transplantation: A case report.
    Milhès J; Marion O; Puissant B; Carlé C; Bouthemy C; Del Bello A; Kamar N; Renaudineau Y; Congy-Jolivet N
    J Transl Autoimmun; 2023 Dec; 7():100223. PubMed ID: 38162455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desensitization Before Living Donor Kidney Transplantation in Highly HLA-Sensitized Patients: A Single-Center Study.
    De Sousa-Amorim E; Revuelta I; Blasco M; Diekmann F; Cid J; Lozano M; Sánchez-Escuredo A; Martorell J; Palou E; Campistol JM; Oppenheimer F
    Transplant Proc; 2015 Oct; 47(8):2332-5. PubMed ID: 26518919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.